By Josh Beckerman
Ocugen Inc. shares recently traded up 11% to $10.26.
The company has been the subject of several articles in Seeking Alpha, Motley Fool and Benzinga, focused on potential World Health Organization approval of the Covaxin Covid-19 vaccine that Ocugen is co-developing with Bharat Biotech for U.S. and Canadian markets.
The stock, which is up 461% for the year to date, is a popular topic on Stocktwits and Reddit.
Write to Josh Beckerman at [email protected]